Yuhan Corporation

KRX:000100.KS

106,400 (KRW) • At close July 3, 2025
Bedrijfsnaam Yuhan Corporation
Symbool 000100.KS
Munteenheid KRW
Prijs 110,000
Beurswaarde 8,090,529,810,000
Dividendpercentage 0.64%
52-weken bereik 76,300 - 166,900
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Wook-Je Cho
Website https://www.yuhan.co.kr

An error occurred while fetching data.

Over Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal

Vergelijkbare Aandelen

SK Biopharmaceuticals Co., Ltd. logo

SK Biopharmaceuticals Co., Ltd.

326030.KS

93,700 KRW

SK bioscience Co.,Ltd. logo

SK bioscience Co.,Ltd.

302440.KS

49,750 KRW

SD BioSensor, Inc logo

SD BioSensor, Inc

137310.KS

10,480 KRW

Hanmi Pharm. Co., Ltd. logo

Hanmi Pharm. Co., Ltd.

128940.KS

293,500 KRW

Hanmi Science Co., Ltd. logo

Hanmi Science Co., Ltd.

008930.KS

43,300 KRW

Green Cross Corporation logo

Green Cross Corporation

006280.KS

134,900 KRW

Daewoong pharmaceutical Co.,Ltd logo

Daewoong pharmaceutical Co.,Ltd

069620.KS

158,800 KRW

Shin Poong Pharm.Co.,Ltd. logo

Shin Poong Pharm.Co.,Ltd.

019170.KS

14,350 KRW

Daewoong Co., Ltd. logo

Daewoong Co., Ltd.

003090.KS

23,600 KRW

Chong Kun Dang Pharmaceutical Corp. logo

Chong Kun Dang Pharmaceutical Corp.

185750.KS

87,400 KRW

Financiële Gegevens

Cijfers zijn in miljoenen (KRW)

Cijfers zijn in miljoenen (KRW)